Mitochondrial aminoacyl tRNA synthetases: implementation of the genetic diagnosis and evaluation of amino acid supplementation as potential therapeutic approach

Amminoacil tRNA sintetasi mitocondriali: implementazione della diagnosi genetica evalutazione della supplementazione di aminoacidi come potenziale approccio terapeutico

Tipologia
Progetti nazionali
Programma di ricerca
RICERCA FINALIZZATA 2016 RF-2016-02361241
Ente finanziatore
Ministero della Salute
Settore ERC
LS2_6 - Molecular genetics, reverse genetics and RNAi
LS4_5 - Metabolism, biological basis of metabolism related disorders
Budget
52.800
Periodo
16/10/2018 - 15/01/2021
Responsabile
Prof.ssa Paola Goffrini

Aree / Gruppi di ricerca

Partecipanti al progetto

Descrizione del progetto

Mitochondrial disorders (MD) are a group of multisystem syndromes with a broad phenotypic spectrum. They are associated with mutations in several genes regulating mitochondrial functions, but the molecular defect remains unknown in a large fraction of MD patients. No effective treatment is available for most MD. The use of Next Generation Sequencing (NGS) approaches has allowed the identification of several new disease-genes and would let to improve genetic diagnosis in MD. Mutations in genes coding mitochondrial aminoacyl tRNA synthetases (mtARSs), the enzymes charging a specific tRNA with its cognate amino acid, have been recently described. Often, but not always, there is a strict genotype-phenotype correlation: thanks to unbiased NGS we will better define this issue. We will generate yeast models to confirm the pathogenicity of novel identified variants. Moreover, on subjects harbouring mtARSs mutations we will evaluate amino acid supplementation as a possible therapeutic approach.

Ultimo aggiornamento: 04/03/2019 10:57
Campusnet SCVSA   |   Versione Mobile
Non cliccare qui!